XML 29 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Segments
3 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Business Segments
11.  Business Segments
 
We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development. Corporate assets include cash and cash equivalents, certain debt issue costs, income tax related assets and certain other assets.
We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.
The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.
     
Three Months
 
For the Periods Ended September 30
   
2018
   
2017
 
Net sales                          
Animal Health
      $ 131,189         $ 128,841    
Mineral Nutrition
        54,838           52,073    
Performance Products
        14,126           12,498    
Total segments
      $ 200,153         $ 193,412    
Depreciation and amortization                          
Animal Health
      $ 5,356         $ 5,254    
Mineral Nutrition
        597           585    
Performance Products
        273           246    
Total segments
      $ 6,226         $ 6,085    
Adjusted EBITDA                          
Animal Health
      $ 35,716         $ 33,742    
Mineral Nutrition
        2,563           3,716    
Performance Products
        716           248    
Total segments
      $ 38,995         $ 37,706    
 
     
Three Months
 
For the Periods Ended September 30
   
2018
   
2017
 
Reconciliation of income before income taxes to Adjusted EBITDA
                         
Income before income taxes
      $ 22,705         $ 18,944    
Interest expense, net
        2,783           3,118    
Depreciation and amortization – Total segments
        6,226           6,085    
Depreciation and amortization – Corporate
        465           559    
Corporate costs
        8,886           7,589    
Stock-based compensation
        565              
Acquisition-related cost of goods sold
                  249    
Acquisition-related accrued compensation
                  437    
Acquisition-related transaction costs
                  400    
Foreign currency (gains) losses, net
        (2,635)           325    
Adjusted EBITDA – Total segments
      $ 38,995         $ 37,706    
 
As of
   
September 30,
2018
   
June 30,
2018
 
Identifiable assets                          
Animal Health
      $ 461,119         $ 455,704    
Mineral Nutrition
        73,895           69,779    
Performance Products
        29,048           24,040    
Total segments
        564,062           549,523    
Corporate
        114,413           122,156    
Total
      $ 678,475         $ 671,679    
 
The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of  $3,491 and $3,432 as of September 30, 2018 and June 30, 2018, respectively. The Performance Products segment includes an investment in an equity method investee of  $528 and $437 as of September 30, 2018 and June 30, 2018, respectively. Corporate assets include cash and cash equivalents, short-term investments, certain debt issuance costs, income tax related assets and certain other assets.